# Trial to Evaluate Topical C-82 in a Psoriasis Plaque Test

> **NCT02432027** · PHASE1,PHASE2 · COMPLETED · sponsor: **Prism Pharma Co., Ltd.** · enrollment: 14 (actual)

## Conditions studied

- Psoriasis

## Interventions

- **DRUG:** C-82 Topical Gel, Placebo
- **DRUG:** C-82 Topical Gel, 1%
- **DRUG:** Daivonex cream
- **DRUG:** Diprosis gel

## Key facts

- **NCT ID:** NCT02432027
- **Lead sponsor:** Prism Pharma Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06
- **Primary completion:** 2015-08
- **Final completion:** 2015-09
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2017-08-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02432027

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02432027, "Trial to Evaluate Topical C-82 in a Psoriasis Plaque Test". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02432027. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*